Press Releases
Home › Press Releases
The news index is intended for investors and media professionals who are looking to learn more about Angiotech. We hope you find this information useful and if you can't find what you are looking for, please feel free to contact us.
All press releases and other information listed below were, to the best of Angiotech's knowledge, timely and accurate when issued. However, the passage of time can render information stale, and you should not rely on the continued accuracy of any such material beyond the date of issuance. Angiotech does not assume the obligation to update this information. All viewers should carefully check the dates of issuance of the material contained in the Angiotech site.
2009
- June 8Angiotech Pharmaceuticals Announces FDA 510(K) Clearance of the Option™ Inferior Vena Cava Filter
- June 3Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
- May 27Angiotech Pharmaceuticals Announces FDA Approval of Next-Generation TAXUS® Liberté® Atom™ Stent System
- May 20Syntax Analysis Finds Treatment With Taxus® Express2® Stent System More Cost Effective Than Bypass Surgery In Patients With Complex Coronary Artery Disease
- May 19Syntax Substudy Shows Positive Outcomes for Left Main Patients Treated with TAXUS® Express2® Stent System
- May 19Angiotech's Corporate Partner, Boston Scientific, Announces Launch of Third-Generation TAXUS® Element™ Stent
- May 19Angiotech Launches E-Commerce Website that Allows Customers to Order Quill™ SRS Product Line
- May 11Angiotech and Boston Scientific Welcome Journal Article Noting Important Differences Between Drug-Eluting Stent Brands
- April 30Correction: Angiotech Pharmaceuticals, Inc. Announces Financial Results for the First Quarter Ended March 31, 2009
- April 24Angiotech Announces Date of Annual General Meeting of Shareholders
- April 16Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast: First Quarter 2009 Financial Results
- April 14New Study Shows that Zilver® PTX™ Effectively Treats Blockages in Critical Thigh Artery
- March 31Angiotech Pharmaceuticals Inc. Announces License Agreement with Baxter International Inc.
- March 9Angiotech Announces Positive Results from Bio-Seal™ Clinical Study
- March 5Angiotech Pharmaceuticals, Inc. Announces Financial Results for the Fourth Quarter Ended December 31, 2008
- March 2Angiotech Pharmaceuticals, Inc. Announces New Senior Secured Term Loan and Credit Facilities
- February 26Correction: Angiotech Receives Approval for Quill™ SRS PDO, MONODERM™ and Nylon Product Lines For Sale in Canada
- February 24Angiotech Pharmaceuticals Announces Time Change of Conference Call and Webcast
- February 17Notice of Conference Call and Webcast: Fourth Quarter and Year End 2008 Financial Results
- February 5Angiotech's Corporate Partner, Boston Scientific, Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
- January 29Angiotech's Corporate Partner, Boston Scientific, Announces Japanese Approval for TAXUS® Liberté® Drug-Eluting Stent System